Compounds > 4,4'-(2,2-bis((4-(aminoiminomethyl)-2-bromophenoxy)methyl)-1,3-propanediyl)bis(oxy))bis(3-bromobenzenecarboximidamide
Page last updated: 2024-09-04

4,4'-(2,2-bis((4-(aminoiminomethyl)-2-bromophenoxy)methyl)-1,3-propanediyl)bis(oxy))bis(3-bromobenzenecarboximidamide and Cancer of Kidney

4,4'-(2,2-bis((4-(aminoiminomethyl)-2-bromophenoxy)methyl)-1,3-propanediyl)bis(oxy))bis(3-bromobenzenecarboximidamide has been researched along with Cancer of Kidney in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gambari, R; Luisi, PL; Menegatti, E; Nastruzzi, C; Walde, P1

Other Studies

1 other study(ies) available for 4,4'-(2,2-bis((4-(aminoiminomethyl)-2-bromophenoxy)methyl)-1,3-propanediyl)bis(oxy))bis(3-bromobenzenecarboximidamide and Cancer of Kidney

ArticleYear
Tumor cell growth inhibition by liposome-encapsulated aromatic polyamidines.
    Journal of pharmaceutical sciences, 1990, Volume: 79, Issue:8

    Topics: Antineoplastic Agents; Benzamidines; Breast Neoplasms; Capsules; Chemistry, Pharmaceutical; Freeze Fracturing; Humans; Kidney Neoplasms; Liposomes; Melanoma; Permeability; Spectrophotometry, Ultraviolet; Tumor Cells, Cultured

1990